SEC Form D · filed April 25, 2018
HEMISPHERX BIOPHARMA INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Adam K. Pascale · Riverton, NJExecThomas K. Equels · ORLANDO, FLExec · DirectorDavid K. Strayer · Riverton, NJExecPeter W. Rodino · Bonita Springs,, FLExecStewart W. Appelrouth · Coral Gables,, FLDirectorWayne K. Springate · Riverton, NJExecWilliam K. Mitchell · Nashville,, TNDirectorAdam K. Pascale · Riverton, NJExecThomas K. Equels · ORLANDO, FLExec · DirectorDavid K. Strayer · Riverton, NJExecPeter W. Rodino · Bonita Springs,, FLExecStewart W. Appelrouth · Coral Gables,, FLDirectorWayne K. Springate · Riverton, NJExecWilliam K. Mitchell · Nashville,, TNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗